These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells. Mithani SK; Balch GC; Shiou SR; Whitehead RH; Datta PK; Beauchamp RD J Surg Res; 2004 Apr; 117(2):296-305. PubMed ID: 15047135 [TBL] [Abstract][Full Text] [Related]
24. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling. Koinuma D; Tsutsumi S; Kamimura N; Taniguchi H; Miyazawa K; Sunamura M; Imamura T; Miyazono K; Aburatani H Mol Cell Biol; 2009 Jan; 29(1):172-86. PubMed ID: 18955504 [TBL] [Abstract][Full Text] [Related]
25. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation. Feinberg MW; Shimizu K; Lebedeva M; Haspel R; Takayama K; Chen Z; Frederick JP; Wang XF; Simon DI; Libby P; Mitchell RN; Jain MK Circ Res; 2004 Mar; 94(5):601-8. PubMed ID: 14752027 [TBL] [Abstract][Full Text] [Related]
26. Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation. Verrecchia F; Tacheau C; Schorpp-Kistner M; Angel P; Mauviel A Oncogene; 2001 Apr; 20(18):2205-11. PubMed ID: 11402315 [TBL] [Abstract][Full Text] [Related]
27. Cathepsin G-mediated activation of pro-matrix metalloproteinase 9 at the tumor-bone interface promotes transforming growth factor-beta signaling and bone destruction. Wilson TJ; Nannuru KC; Singh RK Mol Cancer Res; 2009 Aug; 7(8):1224-33. PubMed ID: 19671689 [TBL] [Abstract][Full Text] [Related]
28. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling. Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129 [TBL] [Abstract][Full Text] [Related]
29. TIEG1 facilitates transforming growth factor-beta-mediated apoptosis in the oligodendroglial cell line OLI-neu. Bender H; Wang Z; Schuster N; Krieglstein K J Neurosci Res; 2004 Feb; 75(3):344-52. PubMed ID: 14743447 [TBL] [Abstract][Full Text] [Related]
30. Restoration of TGF-beta regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells. Xu G; Chakraborty C; Lala PK Biochem Biophys Res Commun; 2002 Jun; 294(5):1079-86. PubMed ID: 12074587 [TBL] [Abstract][Full Text] [Related]
31. Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms a complex with Smad3 and inhibits its transcriptional activity. Grimsby S; Jaensson H; Dubrovska A; Lomnytska M; Hellman U; Souchelnytskyi S FEBS Lett; 2004 Nov; 577(1-2):93-100. PubMed ID: 15527767 [TBL] [Abstract][Full Text] [Related]
32. CITED2 is expressed in human adrenocortical cells and regulated by basic fibroblast growth factor. Haase M; Schott M; Bornstein SR; Malendowicz LK; Scherbaum WA; Willenberg HS J Endocrinol; 2007 Feb; 192(2):459-65. PubMed ID: 17283246 [TBL] [Abstract][Full Text] [Related]
33. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements. Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821 [TBL] [Abstract][Full Text] [Related]
34. GATA-4 is a granulosa cell factor employed in inhibin-alpha activation by the TGF-beta pathway. Anttonen M; Parviainen H; Kyrönlahti A; Bielinska M; Wilson DB; Ritvos O; Heikinheimo M J Mol Endocrinol; 2006 Jun; 36(3):557-68. PubMed ID: 16720723 [TBL] [Abstract][Full Text] [Related]
35. [SMAD3 inhibits the expression of MMP-2 in mouse embryonic fibroblasts]. Mao CM; Yang X; Lü YX; Sun YX; Cheng X; Huang CF Yi Chuan Xue Bao; 2005 Jun; 32(6):633-40. PubMed ID: 16018191 [TBL] [Abstract][Full Text] [Related]
36. BRCA2 and Smad3 synergize in regulation of gene transcription. Preobrazhenska O; Yakymovych M; Kanamoto T; Yakymovych I; Stoika R; Heldin CH; Souchelnytskyi S Oncogene; 2002 Aug; 21(36):5660-4. PubMed ID: 12165866 [TBL] [Abstract][Full Text] [Related]
37. Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model. Kuga H; Morisaki T; Nakamura K; Onishi H; Noshiro H; Uchiyama A; Tanaka M; Katano M Oncogene; 2003 Oct; 22(49):7838-47. PubMed ID: 14586410 [TBL] [Abstract][Full Text] [Related]
39. Induction of human LTBP-3 promoter activity by TGF-beta1 is mediated by Smad3/4 and AP-1 binding elements. Kantola AK; Keski-Oja J; Koli K Gene; 2005 Dec; 363():142-50. PubMed ID: 16223572 [TBL] [Abstract][Full Text] [Related]
40. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. Higashi K; Inagaki Y; Fujimori K; Nakao A; Kaneko H; Nakatsuka I J Biol Chem; 2003 Oct; 278(44):43470-9. PubMed ID: 12917425 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]